Rui Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rui Chen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Changwu Tan
Department of Neurosurgery, Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China
1 shared publicationChuansen Wang
Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China
1 shared publication- Gelei Xiao
Department of Neurosurgery, Xiangya Hospital Central South University Changsha Hunan China
1 shared publication - Hanyan Liu
Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital of Guangzhou Medical University , Guangzhou 510150
1 shared publication - Jing-Da Qiao
Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, the Second Affiliated Hospital, Guangzhou Medical University
1 shared publication - Jingping Liu
Department of General Surgery and NHC Key Laboratory of Transplant Engineering and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication
Latest Publications
- Open Access
- 26 September 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 932955
Novel therapeutic modulators of astrocytes for hydrocephalus
Hydrocephalus is mainly characterized by excessive production or impaired absorption of cerebrospinal fluid that causes ventricular dilation and intracranial hypertension. Astrocytes are the key response cells to inflammation in the central nervous system. In hydrocephalus, astrocytes are activated and show dual characteristics depending on the period of development of the disease. They can suppress the disease in the early stage and may aggravate it in the late stage. More evidence suggests that therapeutics targeting astrocytes may be promising for hydrocephalus. In this review, based on previous studies, we summarize different forms of hydrocephalus-induced astrocyte reactivity and the corresponding function of these responses in hydrocephalus. We also discuss the therapeutic effects of astrocyte regulation on hydrocephalus in experimental studies.
- 26 September 2022
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 15, 932955
Open AccessNovel therapeutic modulators of astrocytes for hydrocephalus
Hydrocephalus is mainly characterized by excessive production or impaired absorption of cerebrospinal fluid that causes ventricular dilation and intracranial hypertension. Astrocytes are the key response cells to inflammation in the central nervous system. In hydrocephalus, astrocytes are activated and show dual characteristics depending on the period of development of the disease. They can suppress the disease in the early stage and may aggravate it in the late stage. More evidence suggests that therapeutics targeting astrocytes may be promising for hydrocephalus. In this review, based on previous studies, we summarize different forms of hydrocephalus-induced astrocyte reactivity and the corresponding function of these responses in hydrocephalus. We also discuss the therapeutic effects of astrocyte regulation on hydrocephalus in experimental studies.
- Open Access
- 8 July 2021
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (12) , 1102-1106
Kallistatin in follicular fluid of women with endometriosis and its correlation with IVF outcome
Endometriosis (EM) affects 10% women of reproductive age and alters fertility. Its management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an endogenou... 背景:子宫内膜异位症(EM)影响10%的育龄妇女并改变其生育能力。它的管理仍然存在争议, 尤其是不孕症的手术和ART的时机。人源性激肽释放酶结合蛋白(KS)是一种内源性蛋白, 调节差异信号通路和生物学功能。然而, EM的功能和潜在的分子机制及其与体外受精(IVF)结局的相关性尚未确定。本研究旨在探讨进行体外受精-胚胎移植 (IVF-ET)的子宫内膜异位症(EM)与非EM患者卵泡液(FF)中K...
- 8 July 2021
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 37 (12) , 1102-1106
Open AccessKallistatin in follicular fluid of women with endometriosis and its correlation with IVF outcome
Endometriosis (EM) affects 10% women of reproductive age and alters fertility. Its management is still debated notably the timing of surgery and ART in infertility. Kallistatin (KS) is an endogenou... 背景:子宫内膜异位症(EM)影响10%的育龄妇女并改变其生育能力。它的管理仍然存在争议, 尤其是不孕症的手术和ART的时机。人源性激肽释放酶结合蛋白(KS)是一种内源性蛋白, 调节差异信号通路和生物学功能。然而, EM的功能和潜在的分子机制及其与体外受精(IVF)结局的相关性尚未确定。本研究旨在探讨进行体外受精-胚胎移植 (IVF-ET)的子宫内膜异位症(EM)与非EM患者卵泡液(FF)中K...